(Q46104542)

19 December 2017

title

Enhancing immune responses by targeting antigen to DC. (English)

1 reference

19 December 2017

author

Irina Caminschi

series ordinal

1

1 reference

19 December 2017

Mireille H. Lahoud

series ordinal

2

1 reference

19 December 2017

author name string

Ken Shortman

series ordinal

3

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

19 December 2017

European Journal of Immunology

published in

1 reference

19 December 2017

volume

39

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

931-938

1 reference

19 December 2017

Transepithelial pathogen uptake into the small intestinal lamina propria.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Gene structure and transcript analysis of the human and mouse EGF-TM7 molecule, FIRE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Targeting the Gut Vascular Endothelium Induces Gut Effector CD8 T Cell Responses Via Cross-Presentation by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Dendritic cells in a mature age.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Steady-state and inflammatory dendritic-cell development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Antigenic targeting of the human mannose receptor induces tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

B cells directly tolerize CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Differential antigen processing by dendritic cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger".

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Enhanced antigen immunogenicity induced by bispecific antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

A potent adjuvant effect of CD40 antibody attached to antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

A fundamental role for interleukin-21 in the generation of T follicular helper cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

In Vivo Targeting of DC-SIGN-positive Antigen-presenting Cells in a Nonhuman Primate Model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839035

7 January 2021

Identifiers

DOI

10.1002/EJI.200839035

1 reference

19 December 2017

PubMed ID

19197943

1 reference

19 December 2017